Hydrophobic Refinement of Polarity-Switchable Lipo-Xenopeptides Modulates Endosomal Escape and Enhances mRNA Delivery In Vitro and In Vivo
Double pH-responsive lipo-xenopeptides combine polar oligoamino acids (OAAs) such as succinoyl tetraethylene pentamine (Stp) with apolar lipoamino fatty acid (LAF) domains. The resulting potent mRNA carriers undergo a profound shift in their polarity upon endosomal protonation. In the current chemical evolution approach, three top-performing xenopeptides based on a U-shaped (LAF<sub>2</sub>Stp<sub>1</sub>, LAF<sub>4</sub>Stp<sub>2</sub>) or bundle (LAF<sub>4</sub>Stp<sub>1</sub>) topology were modified by replacing Stp with a variety of hydrophobized OAAs. Octanol/water distribution (log <i>D</i>) was determined by a novel label-free mass spectrometry-based method. At neutral pH, the new xenopeptide analogues displayed an up to 85-fold higher hydrophobicity (log <i>D</i><sub>7.4</sub> > 2) than Stp-based carriers, with a sharp pH-responsive decrease at endosomal pH (log <i>D</i><sub>5.5</sub> -1). Transfection efficacies were influenced by the amine count of the OAAs, with tetraethylene pentamine outperforming the OAAs with fewer amines. For both topologies, a strong correlation between mRNA expression and endosomal escape, as quantified by calcein release, was found. For U-shaped carriers (LAF/OAA = 2:1), lipophilic OAAs improved endosomal escape and mRNA transfection efficiency. In contrast, for bundle carriers (LAF/OAA = 4:1), lipophilic OAA incorporation did not further enhance endosomal escape or transfection. Mechanistic studies revealed that LAF-xenopeptide polyplexes can adopt both endosomal pH-dependent and pH-independent cytosolic entry mechanisms, with hydrophobization accelerating expression kinetics and enhancing pH-independent entry. Optimized U-shaped xenopeptides were identified with improved mRNA transfection in tumor cells, a dendritic cell line, and low-passage human colon carcinoma cells. In vivo, enhanced mRNA expression was found upon either intramuscular or intravenous administration in several organs and tumor tissue.
Authors
- Daniel Merk (ORCID: https://orcid.org/0000-0003-2935-6919)
- Mina Yazdi
- Jana Pöhmerer
- Olivia M. Merkel (ORCID: https://orcid.org/0000-0002-4151-3916)
- Sophie Thalmayr (ORCID: https://orcid.org/0009-0000-6457-3965)
- Miriam Höhn
- Tobias Burghardt (ORCID: https://orcid.org/0009-0001-4727-6413)
- Matthias Völkl (ORCID: https://orcid.org/0000-0002-8750-8733)
- Lennart Obeser
- Felix Sieber-Schäfer
- Ernst Wagner
- Stefan Zahler
Institutions
- Hokkaido Pharmaceutical University (JP)
- Center for NanoScience (DE)
- LMU Klinikum (DE)
- Pharmaceutical Biotechnology (Czechia) (CZ)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1021/jacs.5c19141
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00